As ERα is known to mediate tumour-promoting effects of 17-β estradiol, our data suggest that adiponectin-triggered increase of ERβ isoform expression might be one important molecular mechanism underlying the protective effects of this adipocytokine. The gene discussed is ESR2; the disease is neoplasm.